CAPTRUST Financial Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-115	Closed	-$3K	–	4284
2022 Q2	$3K	Buy	115 +77	+203%	+$2.01K	﹤0.01%	4369
2022 Q1	$1K	Buy	38 +4	+12%	+$105	﹤0.01%	4777
2021 Q4	$1K	Buy	+34	New	+$1K	﹤0.01%	4658